WO2011054997A3 - Anticuerpo monoclonal que reconoce la proteína gapdh de candida famata - Google Patents

Anticuerpo monoclonal que reconoce la proteína gapdh de candida famata Download PDF

Info

Publication number
WO2011054997A3
WO2011054997A3 PCT/ES2010/070718 ES2010070718W WO2011054997A3 WO 2011054997 A3 WO2011054997 A3 WO 2011054997A3 ES 2010070718 W ES2010070718 W ES 2010070718W WO 2011054997 A3 WO2011054997 A3 WO 2011054997A3
Authority
WO
WIPO (PCT)
Prior art keywords
monoclonal antibody
candida famata
gapdh protein
recognises
antibody
Prior art date
Application number
PCT/ES2010/070718
Other languages
English (en)
French (fr)
Other versions
WO2011054997A2 (es
Inventor
Diana PISA GARCÍA
Luís CARRASCO LLAMAS
Leonor KREMER BARÓN
Original Assignee
Universidad Autónoma De Madrid (Uam)
Consejo Superior De Investigaciones Científicas (Csic)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Autónoma De Madrid (Uam), Consejo Superior De Investigaciones Científicas (Csic) filed Critical Universidad Autónoma De Madrid (Uam)
Publication of WO2011054997A2 publication Critical patent/WO2011054997A2/es
Publication of WO2011054997A3 publication Critical patent/WO2011054997A3/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a un anticuerpo monoclonal, o cualquiera de sus fragmentos, obtenido del hibridoma depositado con nº de acceso ECACC09042201. Dicho anticuerpo es capaz de reconocer la proteína GAPDH de Candida famata. Asimismo, la presente invención se refiere a dicho hibridoma, al epítopo de la proteína GAPDH de Candida famata reconocido por dicho anticuerpo monoclonal, a los usos de hibridoma, anticuerpo o epítopo, o al kit que los comprende. Además, la presente invención se refiere a un método para la detección de Candida famata o para la determinación de la evolución de candidiasis producida por dicho microorganismo.
PCT/ES2010/070718 2009-11-06 2010-11-05 Anticuerpo monoclonal que reconoce la proteína gapdh de candida famata WO2011054997A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200930966A ES2359203B9 (es) 2009-11-06 2009-11-06 Anticuerpo monclonal que reconoce la proteína gapdh de candida famata.
ESP200930966 2009-11-06

Publications (2)

Publication Number Publication Date
WO2011054997A2 WO2011054997A2 (es) 2011-05-12
WO2011054997A3 true WO2011054997A3 (es) 2011-06-30

Family

ID=43927601

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2010/070718 WO2011054997A2 (es) 2009-11-06 2010-11-05 Anticuerpo monoclonal que reconoce la proteína gapdh de candida famata

Country Status (2)

Country Link
ES (1) ES2359203B9 (es)
WO (1) WO2011054997A2 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052053A1 (en) * 1999-03-01 2000-09-08 Research And Development Institute, Inc. Antibodies against phosphomannan that are protective against candidiasis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052053A1 (en) * 1999-03-01 2000-09-08 Research And Development Institute, Inc. Antibodies against phosphomannan that are protective against candidiasis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DELGADO M.L. ET AL: "Candida albicans TDH3 gene promotes secretion of internal invertase when expressed in Saccharomyces cerevisiae as a glyceraldehyde-3-phosphate dehydrogenase-invertase fusion protein", YEAST, vol. 20, no. 8, June 2003 (2003-06-01), pages 713 - 722 *

Also Published As

Publication number Publication date
ES2359203A1 (es) 2011-05-19
ES2359203B9 (es) 2013-02-19
ES2359203B1 (es) 2012-06-21
WO2011054997A2 (es) 2011-05-12

Similar Documents

Publication Publication Date Title
WO2010046775A3 (en) Methods for producing antibodies from plasma cells
WO2010042562A3 (en) Muc1* antibodies
WO2013037484A8 (en) ANTI-αβTCR ANTIBODY
WO2017132627A3 (en) Screening methods for identifying antibodies that bind cell surface epitopes
NZ591541A (en) Pcsk9 antagonists
WO2004072266A3 (en) Antibody affinity engineering by serial epitope-guided complementarity replacement
WO2010121093A3 (en) Humanized antibody compositions and methods for binding lysophosphatidic acid
WO2009136382A3 (en) Antibodies to receptor of advanced glycation end products (rage) and uses thereof
WO2011131746A3 (en) Heterodimeric antibody fc-containing proteins and methods for production thereof
WO2010145792A8 (en) Bispecific antigen binding proteins
NZ587198A (en) Monoclonal antibodies against the rgm a protein and uses thereof
WO2009052400A8 (en) Antibodies that bind to mammalian ngal and uses thereof
IL202232A (en) A method of making a human antibody derived from a rabbit parent antibody that binds to a desired antigen as well as a human antibody or fragment thereof produced by this method
MX2009004532A (es) Composiciones y metodos para unir esfingosina-1-fosfato.
IN2012DN03911A (es)
WO2009135181A3 (en) Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
JP2010513228A5 (es)
CL2010000470A1 (es) Anticuerpo que se une a efrina-b2 que comprende la region variable de la cadena liviana y pesada bvr-l1, hvr-l2, hvr-h1, hvr-h2 y hvr-h3; polinucleotido que codifica dicho anticuerpo; vector y celula huesped que comprende al polinucleotido; metodo para elaborar el anticuerpo, detectar efrina-b2; y uso de dicho anticuerpo.
WO2009048537A3 (en) Humanized antibody
JP2010509937A5 (es)
NZ595863A (en) Antibodies to egfl7 and methods for their use
WO2008065384A3 (en) Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor
WO2007001895A3 (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
WO2012175602A3 (en) Elisa for calprotectin
WO2008052108A3 (en) Methods for use in human-adapting monoclonal antibodies

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10827948

Country of ref document: EP

Kind code of ref document: A2